# Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

> **NCT06233708** · — · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 2092 (actual)

## Conditions studied

- Hepatocellular Carcinoma Recurrent
- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Non-Selective Beta-Adrenoreceptor Agonists for Systemic Use

## Key facts

- **NCT ID:** NCT06233708
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 2092 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06233708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06233708, "Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06233708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*